• Leitud 15 kirjet
Kivastik, T.; Krass, M.; Koiv, K.; Liljequist, S. (2003). Effect of NMDA receptor antagonist ifenprodil on the mesolimbic dopaminergic activity. European Journal of Pharmaceutical Sciences, 19, S24−S24.5.1.
Piepponen, TP.; Honkanen, A.; Mikkola, JAV.; Kivastik, T.; Ahtee, L. (2003). mu-Opioid receptors in cerebral dopaminergic transmission. European Journal of Pharmaceutical Sciences, 19, S7−S7.5.1.
Haidkind, M.; Kivastik, T.; Eller, M.; Kolts, I.; Oreland, L.; Harro, J. (2002). Denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSPA [N(2-chloroethyl)-N-ethyl-2-bromobenzylaminel reduces dopamine release potential in the nucleus accumbens shell in conscious rats. Neuroscience Letters, 332 (2), 79−82.1.1.
Harro, J.; Eller, M.; Haidkind, R.; Kivastik, T.; Terasmaa, A.; Kolts, I.; Rinken, A.; Oreland, L. (2002). Changes in dopamine release, metabolism and D2 receptors after denervation of the locus coeruleus projections. European Neuropsychopharmacology, 12, S222−S222.5.1.
Piepponen, TP.; Zharkovsky, A.; Kivastik, T.; Ahtee, L. (1999). Effects of morphine in rats withdrawn from repeated nifedipine administration. European Journal of Pharmacology, 365, 159−164.1.1.
Piepponen, TP.; Honkanen, A.; Kivastik, T.; Zharkovsky, A.; Turtia, A.; Mikkola, JAV.; Ahtee, L. (1999). Involvement of opioid mu(1)-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission. Pharmacology Biochemistry and Behavior, 63 (2), 245−252.1.1.
Kask, A.; Kivastik, T.; Rago, L.; Harro, J. (1999). Neuropeptide YY1 receptor antagonist BIBP3226 produces conditioned place aversion in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 23 (4), 705−711.1.1.
Cebere, A.; Hou, YN.; Cebers, G.; Kivastik, T.; Liljequist, S. (1998). Effects of chronic ethanol exposure on NMDA-induced Ca2+ fluxes, neurotoxicity and AP-1 transcription factor activity in cultured cerebellar granule cells. European Journal of Neuroscience, 10, 441−441.5.1.
Piepponen, TP.; Kivastik, T.; Katajamaki, J.; Zharkovsky, A.; Ahtee, L. (1997). Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats. Pharmacology Biochemistry and Behavior, 58 (1), 275−279.1.1.
Piepponen, TP.; Katajamaki, J.; Kivastik, T.; Zharkovsky, A.; Ahtee, L. (1996). Behavioural and neurochemical sensitization of morphine-withdrawn rats to quinpirole. Pharmacology Biochemistry and Behavior, 54 (4), 787−792.1.1.
Pokk, P.; Kivastik, T.; Sobol, D.; Liljequist, S.; Zharkovsky, A. (1996). Is upregulation of benzodiazepine receptors a compensatory reaction to reduced GABAergic tone in the brain of stressed mice? Naunyn-Schmiedebergs Archives of Pharmacology, 354 (6), 703−708.1.1.
Kivastik, T.; Vuorikallas, K.; Piepponen, TP.; Zharkovsky, A.; Ahtee, L. (1996). Morphine- and cocaine-induced conditioned place preference: Effects of quinpirole and preclamol. Pharmacology Biochemistry and Behavior, 54 (2), 371−375.1.1.
Kivastik, T.; Rutkauskaite, J.; Zharkovsky, A. (1996). Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacology Biochemistry and Behavior, 53 (4), 1013−1015.1.1.
Piepponen, TP.; Kivastik, T.; Katajamaki, J.; Zharkovsky, A.; Ahtee, L. (1994). Naloxonazine reveals the role of mu-1-opioid receptor in the rewarding effects of morphine. Regulatory Peptides, 53, 221−222.1.1.
Zharkovsky, A.; Moisio, J.; Kivastik, T.; Ahtee, L. (1993). Role of dopamine-receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats. Naunyn-Schmiedebergs Archives of Pharmacology, 347, 478−482.1.1.